Artificial Intelligence-powered biopharma firm BPGbio, which focuses on oncology, neurology and treatments for rare diseases, leased approximately 70,000 square feet of lab and office space at 300 Third Avenue, a recently built speculative development by Lincoln Property Co. and MetLife Investment Management situated along the 128 Tech Corridor in suburban Waltham, Massachusetts.
Lincoln Property Lands Another Biotech Company at 300 Third Ave.
Headquarters Lease for BPGBio Nearly Fills Speculative Life Science Facility in Waltham, Massachusetts
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Companies
- Lincoln Property Company
Real Estate
- MetLife, Inc
Finance and Insurance
- BPGbio
Manufacturing
- Contacts
- Tim Latham
Senior Vice President, Leasing, Lincoln Property Company
- Chris Devaux
Vice President, Lincoln Property Company
- Nathaniel Heilbron
Senior Advisor, Cresa
- Adam Subber
Managing Principal, Cresa
- Christopher Scott
Senior Vice President, Lincoln Property Company